BC
GH icon

Bayforest Capital’s Guardant Health GH Stock Holding History

Bayforest Capital’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.5K Sell
10
-249
-96% -$27.1K ﹤0.01% 891
2026
Q1 		$23.9K Buy
+259
New +$26K 0.03% 703
2025
Q4 		– Sell
-1,250
Closed -$78.1K – 850
2025
Q3 		$78.1K Buy
+1,250
New +$68K 0.04% 553
2025
Q2 		– Sell
-214
Closed -$9.12K – 814
2025
Q1 		$9.12K Sell
214
-6,712
-97% -$290K ﹤0.01% 662
2024
Q4 		$212K Buy
+6,926
New +$195K 0.27% 127

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Bayforest Capital's GH Position: Q2 2026 in Review

Bayforest Capital reduced its Guardant Health (GH) stake by 96% in Q2 2026, selling an estimated $27.1K and leaving 10 shares worth $1.5K. The position accounts for ﹤0.01% of the portfolio, ranked #891.

Bayforest Capital first reported a position in GH in Q4 2024 and has held it in 5 quarters since. The position peaked at $212K in Q4 2024. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Bayforest Capital held 10 shares of Guardant Health worth $1.5K as of Q2 2026.
  • Bayforest Capital sold 249 Guardant Health shares in Q2 2026, an estimated $27.1K.
  • Guardant Health made up ﹤0.01% of Bayforest Capital's portfolio in Q2 2026, its #891 holding.
  • Bayforest Capital first reported a position in Guardant Health in Q4 2024 and has held it in 5 quarters since.
  • Bayforest Capital's Guardant Health position peaked at $212K in Q4 2024.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.